The interchangeability of PD-L1 scoring systems and assays in gastroesophageal cancer – EORTC

EORTC (European Organisation for Research and Treatment of Cancer) shared a post on X:

”Proud to share a new EORTC publication on RP-2321-GITCG ASPIRE, the first global study evaluating the interchangeability of programmed death-ligand 1 (PD-L1) scoring systems and assays in gastroesophageal cancer.

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol.

Authors: Angelica Petrillo, Lindsey Oudijk, Raghav Sundar, C. Daumer, J. Casas, D. D’haese, Murielle Mauer, Nicole van Grieken, Elizabeth Catherine Smyth, Markus Moehler.”

Source: EORTC/X